11/05
2021

Update on New and Emerging Therapies for the Treatment of Heart Failure

1:30 pm - 2:30 pm
Off Campus
Adam Scala, PharmD

Update on New and Emerging Therapies for the Treatment of Heart Failure

Schedule:         November 5, 2021, 1:30 pm to 2:30 pm, Dartmouth-Hitchcock Medical Center, Lebanon, NH

Audience:        Accredited for Pharmacists

                         Other interested health care professionals welcome

Credits:           1 Contact Hour knowledge based, 0.1CEU will be awarded under the provider, 0837-9999-21-225-L01-P                                  

Presenter:        Adam Scala, PharmD, RPh, PGY1 Acute Care Pharmacy Resident, Dartmouth-Hitchcock

Registration:    Free to all attendees

Learning Objectives:

After attending this program, participants will be able to:

  1. Identify the differences between the 2017 ACC Heart Failure with Reduced Ejection Fraction Guidelines to the 2021 Guideline Update
  2. Describe the current literature on the use of different medications that have been approved or further studied since the publication of the 2017 ACC Heart failure Reduced Ejection Fraction Guidelines
  3. Select an appropriate treatment plan for heart failure based on a stage, functional status, and patient characteristics

Requirements for Receiving CE Credit:

  • Successful completion of post-presentation questions
  • Participation at live program
  • Complete program evaluation form